160 related articles for article (PubMed ID: 15368926)
21. PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease.
Banner KH; Trevethick MA
Trends Pharmacol Sci; 2004 Aug; 25(8):430-6. PubMed ID: 15276712
[TBL] [Abstract][Full Text] [Related]
22. Phosphodiesterase 4-selective inhibition: novel therapy for the inflammation of COPD.
Jeffery P
Pulm Pharmacol Ther; 2005; 18(1):9-17. PubMed ID: 15607122
[TBL] [Abstract][Full Text] [Related]
23. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.
Sanz MJ; Cortijo J; Morcillo EJ
Pharmacol Ther; 2005 Jun; 106(3):269-97. PubMed ID: 15922015
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation and molecular modelling studies on benzothiadiazine derivatives as PDE4 selective inhibitors.
Tait A; Luppi A; Hatzelmann A; Fossa P; Mosti L
Bioorg Med Chem; 2005 Feb; 13(4):1393-402. PubMed ID: 15670947
[TBL] [Abstract][Full Text] [Related]
25. Frontrunners in novel pharmacotherapy of COPD.
Barnes PJ
Curr Opin Pharmacol; 2008 Jun; 8(3):300-7. PubMed ID: 18457992
[TBL] [Abstract][Full Text] [Related]
26. Future treatment of chronic obstructive pulmonary disease.
Di Maria G; Spicuzza L; Mazzarella G
Monaldi Arch Chest Dis; 2002; 57(3-4):200-5. PubMed ID: 12619385
[TBL] [Abstract][Full Text] [Related]
27. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
28. [Efficient treatments for COLD in the twenty-first century?].
Aubier M
Presse Med; 2004 Jul; 33(13):845-6. PubMed ID: 15387379
[No Abstract] [Full Text] [Related]
29. Novel approaches to using PDE4 inhibitors for antihypertensive therapy.
Wang D; Wang T
Curr Opin Investig Drugs; 2005 Mar; 6(3):283-8. PubMed ID: 15816505
[TBL] [Abstract][Full Text] [Related]
30. Chronic Obstructive Pulmonary Disease--SMi's Second Annual Conference. 10-11 March 2004, London, UK.
De La Rue SA
IDrugs; 2004 Apr; 7(4):318-22. PubMed ID: 15057634
[TBL] [Abstract][Full Text] [Related]
31. New therapies for chronic obstructive pulmonary disease.
Barnes PJ
Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
[TBL] [Abstract][Full Text] [Related]
32. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
33. New treatments for COPD.
Barnes PJ
Nat Rev Drug Discov; 2002 Jun; 1(6):437-46. PubMed ID: 12119745
[TBL] [Abstract][Full Text] [Related]
34. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.
Castro A; Jerez MJ; Gil C; Martinez A
Med Res Rev; 2005 Mar; 25(2):229-44. PubMed ID: 15514991
[TBL] [Abstract][Full Text] [Related]
35. COPD: is there light at the end of the tunnel?
Barnes PJ
Curr Opin Pharmacol; 2004 Jun; 4(3):263-72. PubMed ID: 15140418
[TBL] [Abstract][Full Text] [Related]
36. Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease.
Soto FJ; Hanania NA
Curr Opin Pulm Med; 2005 Mar; 11(2):129-34. PubMed ID: 15699784
[TBL] [Abstract][Full Text] [Related]
37. The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD.
Fox JC; Fitzgerald MF
Curr Opin Pharmacol; 2009 Jun; 9(3):231-42. PubMed ID: 19356979
[TBL] [Abstract][Full Text] [Related]
38. An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease.
Giembycz MA
Br J Clin Pharmacol; 2006 Aug; 62(2):138-52. PubMed ID: 16842388
[TBL] [Abstract][Full Text] [Related]
39. Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD.
Huang Z; Mancini JA
Curr Med Chem; 2006; 13(27):3253-62. PubMed ID: 17168849
[TBL] [Abstract][Full Text] [Related]
40. A role for phosphodiesterase type-4 inhibitors in COPD?
Johnson DC
Lancet; 2001 Jul; 358(9278):256-7. PubMed ID: 11498207
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
